Rate Cut On Devices May Not Offer Relief To Covid Patients
New Delhi : Relief to consumers from a reduction in goods and services tax (GST) on medical supplies could be less than expected, with a section of the industry voicing fears…
Oxygen banks, generation plants key to tackling 3rd wave: Experts
PUNE: With the second wave of the pandemic firmly on the ebb, medical experts have laid stress on oxygen banks for private hospitals and oxygen plants at civic hospitals to avoid a repeat of…
Govt Job for Pharmacists under ESI Scheme
The Employees State Insurance Scheme (ESI Scheme) is an integrated measure of Social Insurance embodied in the Employees State Insurance Act and it is designed to accomplish the task of…
FDA denies emergency use nod for Covaxin in US
New Delhi: The US Food and Drug administration has denied approval for emergency use of Bharat Biotech’s Covaxin, and has asked for additional data, biopharmaceutical Ocugen, the US partner of the Indian…
Why big pharma had a responsibility to profit from the pandemic
The pharmaceutical company Pfizer expects to earn up to US$26 billion (£18 billion) this year from the sale of its COVID-19 vaccine. Profits for the first quarter of 2021 are apparently 44% higher…
Experts Question Covaxin’s High Private Market Price As R&D Was Govt Subsidised
MUMBAI : The pricing of indigenously-manufactured Covid-19 vaccine, Covaxin, developed by Bharat Biotech, which at Rs 1,410 per dose is almost double that of Serum Institute’s Covishield has raised heckles in…
Govt Job for Senior Resident Doctors at AIIMS
All India Institute of Medical Sciences (AIIMS), Jodhpur has released govt medical jobs recruitment of 106 vacancies for Senior Resident Posts. All India Institute of Medical Science released plenty of jobs…
Moderna offers to sell booster shots from January; indemnity-waiver talks on
New Delhi: US vaccine maker Moderna has offered to sell booster doses of its Covid vaccine to India, from January 2022 even as the government continues to hold negotiations with Moderna and J&J on the indemnity…
Suven Pharma inks non-exclusive licencing pact with IICT, NIIST for 2-DG & Molnupiravir process tech
Hyderabad: After licencing the process knowhow for synthesis of Covid-19 wonder drug 2-DG (2-Deoxy-D-Glucose) to Lee Pharma, the Indian Institute of Chemical Technology (IICT) has now inked a similar pact with another Hyderabad-based player Suven Pharmaceuticals for…
Govt Job for Pharmacists at AIIMS
AIIMS Jodhpur is one of the SIX NEW AIIMS established by the Ministry of Health & Family Welfare, Government of India under the Pradhan Mantri Swasthya Suraksha Yojna (PMSSY) with the…
